# Cannabinoid Hyperemesis Syndrome: What Symptoms to Watch For > **Author:** Benjamin Caplan, MD (ABFM Board Certified, MA Lic. #240562, NPI: 1962722637) > **Publisher:** CED Clinic (https://cedclinic.com) > **Canonical URL:** https://cedclinic.com/cannabinoid-hyperemesis-syndrome-symptoms-watch/ > **Published:** 2026-03-02T14:55:30-04:00 | **Last Modified / Clinically Audited:** 2026-09-28T11:13:04-04:00 > **Clinical Summary:** Learn about cannabinoid hyperemesis syndrome symptoms, diagnosis, and treatment to improve early recognition and management in chronic cannabis users. --- ✦ New CED Clinical Relevance #72 Notable Clinical Interest Emerging findings or policy developments worth monitoring closely. SafetyNeurologyResearch Why This Matters Cannabinoid hyperemesis syndrome (CHS) represents an emerging clinical entity that clinicians must recognize given the rising prevalence of [cannabis use](https://cedclinic.com/cannabis-cardiovascular-health-insights-2024/), particularly high-potency products, which increases the likelihood of encountering this paradoxical condition in practice. Early identification of CHS is critical because patients often undergo extensive gastrointestinal workup and unnecessary interventions before diagnosis, while the definitive treatment—cannabis cessation—remains underutilized without clinical awareness. Understanding the constellation of symptoms associated with CHS improves diagnostic accuracy and reduces morbidity in a population with expanding cannabis access. Clinical Summary [Cannabis hyperemesis syndrome](https://cedclinic.com/remediated-cannabis-mold-contamination-risks/) is an increasingly recognized clinical entity affecting chronic heavy cannabis users, characterized by cyclical episodes of severe nausea, vomiting, and abdominal pain that paradoxically respond to hot water immersion or bathing. The rising incidence of CHS presentations reflects both increased cannabis potency and consumption patterns, particularly with the availability of high-THC products and concentrates in legalized markets. Clinicians should maintain a high index of suspicion for CHS in patients presenting with recurrent unexplained nausea and vomiting, especially those reporting heavy daily [cannabis use](https://cedclinic.com/cannabis-cardiovascular-health-insights-2024/) and atypical responses to standard antiemetic therapy. The diagnosis is primarily clinical and based on symptom pattern and cannabis exposure history, as no specific biomarkers currently exist. Understanding CHS pathophysiology and presentation is essential for avoiding unnecessary diagnostic workup and inappropriate treatments in this growing patient population. Physicians should counsel heavy cannabis users about CHS risk and consider cannabis cessation as the definitive therapeutic intervention, while recognizing that patient education regarding this syndrome may improve early identification and appropriate management. Dr. Caplan’s Take “Cannabis hyperemesis syndrome represents a real and increasingly common clinical presentation that we’re seeing in heavy, frequent users, particularly those consuming high-potency products, and it demands we take seriously the difference between cannabis use and cannabis abuse in our patient populations.” Clinical Perspective Cannabinoid hyperemesis syndrome (CHS) represents an increasingly recognized clinical entity characterized by cyclical nausea, vomiting, and abdominal pain in chronic cannabis users, with symptoms often paradoxically improving with hot showers. The syndrome’s pathophysiology remains incompletely understood, though theories suggest dysregulation of [cannabinoid receptors](https://cedclinic.com/citral-cannabinoid-receptor-2-activation-pain-relief/) in the central nervous system and altered thermoregulation contribute to symptom manifestation. Recognition of CHS is clinically important as affected patients frequently undergo extensive diagnostic workups and interventions before cannabis cessation is identified as definitive treatment. The rising prevalence of CHS correlates with increased cannabis potency and frequency of use in recent years, making clinician awareness and patient education essential components of comprehensive care. Early identification based on characteristic symptom patterns and detailed substance use history can prevent unnecessary investigations and facilitate appropriate management. 💬 Join the Conversation Have a question about how this applies to your situation? [Ask Dr. Caplan →](https://benjamincaplan.com/ask-dr-caplan) Want to discuss this topic with other patients and caregivers? [Join the forum discussion →](https://cedclinic.com/interact/discussion-forums/) Have thoughts on this? Share it: [𝕏 Share on X](https://twitter.com/intent/tweet?text=Just+read+this+on+CEDclinic.com%3A+Cannabis+hyperemesis+syndrome+is+on+the+rise%3A+What+symptoms+to+watch+for+%7C+AllSides+%40drcaplan&url=https%3A%2F%2Fwww.allsides.com%2Fnews%2F2026-03-02-0800%2Fpublic-health-cannabis-hyperemesis-syndrome-rise-what-symptoms-watch) [in Share on LinkedIn](https://www.linkedin.com/sharing/share-offsite/?url=https%3A%2F%2Fwww.allsides.com%2Fnews%2F2026-03-02-0800%2Fpublic-health-cannabis-hyperemesis-syndrome-rise-what-symptoms-watch) [🦅 Share on BlueSky](https://bsky.app/intent/compose?text=Just+read+this%3A+Cannabis+hyperemesis+syndrome+is+on+the+rise%3A+What+symptoms+to+watch+for+%7C+AllSides+--+via+%40drcaplan.bsky.social+https%3A%2F%2Fwww.allsides.com%2Fnews%2F2026-03-02-0800%2Fpublic-health-cannabis-hyperemesis-syndrome-rise-what-symptoms-watch) [📷 Follow on Instagram](https://www.instagram.com/drbenjamincaplan/) [📝 Read more on Substack](https://substack.com/@doctorapproved) [🔔 Subscribe via RSS](https://cedclinic.com/category/cannabis-news/feed/) Related Articles - [Daily Digest: Last 24 Hours: Pain, Policy, and the Psychiatric Tradeoffs of Cannabis — March 01, 2026](https://cedclinic.com/2026-cannabis-psychiatric-tradeoffs-pain-policy/) - [Cannabis Hyperemesis Syndrome: Clinical Signs to Watch](https://cedclinic.com/cannabis-hyperemesis-syndrome-clinical-signs/) - [Daily Digest: Last 48 Hours: CHS, Prenatal Risk, and the Limits of THC Blood Testing — March 01, 2026](https://cedclinic.com/limits-thc-blood-testing-cannabis-clinical-updates-2026/) 📰 Source: [https://www.allsides.com/news/2026-03-02-0800/public-health-cannabis-hyperemesis-syndrome-rise-what-symptoms-watch](https://www.allsides.com/news/2026-03-02-0800/public-health-cannabis-hyperemesis-syndrome-rise-what-symptoms-watch) Further Reading Evidence Watch[The Brain Science Behind the Munchies – Nautilus Magazine](https://cedclinic.com/cannabis-appetite-stimulation-neuroscience/) Evidence WatchIGC Pharma Adds Visionary Investigators Network as Clinical Site to Phase 2 CALMA Trial Cannabis Policy Wire[Policy Watch: 20 Regulatory Updates — March 10, 2026](https://cedclinic.com/dea-scheduling-synthetic-opioids-regulatory-updates-2026/) [https://cedclinic.com/contact/](https://cedclinic.com/contact/) Physician-Led, Whole-Person Care A doctor who takes the time to truly understand you. Personal care that starts with listening and is guided by experience and ingenuity. Health, Longevity, Wellness One-on-One Cannabis Guidance Metabolic Balance [Leave a Message](https://cedclinic.com/contact/) [Metabolic Care](https://cedclinic.com/metabolic/metabolic-how-it-works/) [Medical Consulting](https://cedclinic.com/book/) [Cannabis Care](https://cedclinic.com/book/) [https://cedclinic.com/contact/](https://cedclinic.com/contact/) RELATED READING AT CED CLINIC Continue exploring the evidence [Screaming, vomiting, and daily weed: The rise of 'scromiting' among chronic cannabis users](https://cedclinic.com/cannabinoid-hyperemesis-syndrome-clinical-overview/) Explore the increasing reports of severe vomiting episodes linked to [chronic cannabis use](https://cedclinic.com/cannabis-tolerance-behavioral-models/), known as 'scromiting'. [Read More](https://cedclinic.com/cannabinoid-hyperemesis-syndrome-clinical-overview/) [Cannabis Hyperemesis Syndrome cases rise nationwide as providers warn of growing …](https://cedclinic.com/cannabis-hyperemesis-syndrome-cases-surge-nationwide/) A nationwide overview of the rising incidence of cannabinoid hyperemesis syndrome and clinical warnings. [Learn More](https://cedclinic.com/cannabis-hyperemesis-syndrome-cases-surge-nationwide/) [Why Some Heavy Cannabis Users Can't Stop Throwing Up, According to New Research](https://cedclinic.com/cannabinoid-hyperemesis-heavy-cannabis-vomiting/) New research sheds light on the mechanisms behind persistent vomiting in heavy cannabis users. [Discover Insights](https://cedclinic.com/cannabinoid-hyperemesis-heavy-cannabis-vomiting/) ### Related --- ### Verification & Medical Governance - **Lead Clinical Author:** Benjamin Caplan, MD - **Credentials:** Board Certified in Family Medicine (ABFM), Former CMO Canna Care Docs (250,000+ patients supervised), Founder & CMO CED Clinic & CED Foundation, Author of *The Doctor-Approved Cannabis Handbook* (Penguin Random House). - **Clinical Scale:** 350,000+ lifetime evaluations overseen; 81,008-patient Real-World Evidence Registry (`~/.ced_rwe_vault.db`); 125,000+ peer-reviewed study literature observatory (`http://localhost:8768/api/explorer/terminal`). - **License Verification:** Commonwealth of Massachusetts License #240562 (https://checkahealthlicense.mass.gov/). - **NPI Registry:** 1962722637 (https://npiregistry.cms.hhs.gov/provider-view/1962722637). - **Ethics & Data Privacy:** Clinical registry observations adhere strictly to HIPAA Safe Harbor de-identification (45 CFR § 164.514(b)) and criteria for secondary research exemption under 45 CFR § 46.104(d)(4).